Capitalizator.

Capitalize Yourself: Right Data. Real Growth.

Sector Analysis

Services-Commercial Physical & Biological Research

Standard Industrial Classification: SIC 8731

Industry Insider Sentiment Analysis

The Services-Commercial Physical & Biological Research sector (SIC 8731) acts as a critical barometer for broader economic health. Our real-time monitoring reveals total transactions. Monitoring "cluster buying" is one of the most reliable leading indicators for future sector performance. By analyzing aggregate data across this specific Standard Industrial Classification, investors can filter out individual company volatility and identify high-conviction trends. When multiple directors and officers within the same industry move capital simultaneously, it often signals an upcoming sector-wide revaluation or a fundamental shift in supply chain dynamics that has yet to be recognized by the broader public market.

Filing Date Trade Date Ticker Company Reporting Person Relationship Type Price Qty Total, $ Owned After
2026-11-19 21:30 2026-09-22 BIAF bioAffinity Technologies, Inc. HRT FINANCIAL LP 10% owner SELL $7.24 162,219 $1,175,050 116,658
2026-11-19 21:30 2026-09-22 BIAF bioAffinity Technologies, Inc. HRT FINANCIAL LP 10% owner BUY $7.52 138,244 $1,039,664 116,658
2026-11-18 21:04 2026-11-16 INCY INCYTE CORP Stein Steven H Officer OPT+S $121.98 576 $70,260 30,916
2026-11-18 21:03 2026-11-16 INCY INCYTE CORP CAGNONI PABLO J Officer OPT+S $120.96 2,642 $319,588 183,200
2026-11-18 21:38 2026-11-17 MXCT MAXCYTE, INC. Masoud Maher Director, Officer BUY $1.21 100,000 $120,780 575,000
2026-11-17 21:27 2026-11-13 INCY INCYTE CORP Heeson Lee Officer SELL $120.82 10,694 $1,292,032 26,884
2026-11-16 21:15 2026-11-12 ICLR ICON PLC Murray Ciaran Director SELL $200.18 10,000 $2,001,765 7,000
2026-11-13 00:42 2026-11-09 IQV IQVIA HOLDINGS INC. Sherbet Eric Officer OPT+S $278.83 4,446 $1,239,678 24,989
2026-11-10 21:07 2026-11-06 INCY INCYTE CORP Stein Steven H Officer OPT+S $118.39 240,193 $28,435,753 30,916
2026-11-05 21:08 2026-11-03 INCY INCYTE CORP Tray Thomas Officer SELL $118.96 610 $72,566 21,126
2026-11-04 11:30 2026-11-02 ICLR ICON PLC Murray Ciaran Director SELL $205.67 3,452 $709,956 17,000
2026-11-03 21:11 2026-11-02 ICLR ICON PLC Clerkin Nigel Bernard John Officer OPT+S $206.66 1,488 $307,503 7,171
2026-11-03 21:16 2026-11-02 ICLR ICON PLC Lyons Emer Officer OPT+S $206.66 264 $54,558 1,217
2026-11-03 21:23 2026-11-02 ICLR ICON PLC Balfe Barry Edward Director, Officer OPT+S $206.66 5,175 $1,069,441 9,291
2026-11-02 23:24 2026-10-29 MEDP Medpace Holdings, Inc. EWALD STEPHEN P Officer SELL $690.00 1,245 $859,050 19,098
2026-10-28 20:23 2026-10-26 MEDP Medpace Holdings, Inc. BURWIG SUSAN E Officer OPT+S $677.00 20,000 $13,540,000 54,012
2026-10-26 20:51 2026-10-22 CRL CHARLES RIVER LABORATORIES INTERNATIONAL, INC. FOSTER JAMES C Director OPT+S $350.00 24,042 $8,414,700 31,596
2026-10-26 10:57 2026-10-23 ICLR ICON PLC Lyons Emer Officer OPT+S $182.37 272 $49,604 990
2026-10-23 22:45 2026-10-21 CRL CHARLES RIVER LABORATORIES INTERNATIONAL, INC. Parisotto Shannon M Officer OPT+S $344.41 2,156 $742,548 4,807
2026-10-23 17:35 2026-09-08 BUDZ WEED, INC. BREEN NICOLE M Director, Officer, 10% owner SELL $0.03 120,000 $3,600 29,749,930
2026-10-19 20:38 2026-10-15 INCY INCYTE CORP CAGNONI PABLO J Officer OPT+S $112.71 2,642 $297,780 183,200
2026-10-14 00:32 2026-10-09 ONMD OneMedNet Corp Yu Jeffrey Director, Officer, 10% owner BUY $5.54 45,126 $249,998 896,840
2026-10-14 00:32 2026-10-07 ONMD OneMedNet Corp Kosasa Thomas Director, 10% owner BUY $5.78 129,758 $750,001 1,983,573
2026-10-10 01:30 2026-09-22 ONMD OneMedNet Corp Green Aaron Director, Officer SELL $7.16 6,667 $47,762 247,971
2026-10-10 01:30 2026-09-14 ONMD OneMedNet Corp Golden Robert Lawrence Director, Officer SELL $6.50 8,500 $55,290 91,291
2026-10-08 00:32 2026-10-05 CRL CHARLES RIVER LABORATORIES INTERNATIONAL, INC. Parisotto Shannon M Officer OPT+S $308.44 981 $302,580 4,807
2026-10-02 20:27 2026-09-30 CRL CHARLES RIVER LABORATORIES INTERNATIONAL, INC. Coleman Glenn Officer BUY $297.43 10 $2,974 27,762
2026-10-01 21:43 2026-09-29 MEDP Medpace Holdings, Inc. Troendle August J. Director, Officer, 10% owner SELL $623.03 48,667 $30,320,928 338,225
2026-09-29 20:13 2026-09-25 MEDP Medpace Holdings, Inc. Troendle August J. Director, Officer, 10% owner SELL $620.10 2,564 $1,589,941 386,892
2026-09-25 20:22 2026-09-23 MEDP Medpace Holdings, Inc. Troendle August J. Director, Officer, 10% owner SELL $624.01 43,916 $27,403,896 389,456
2026-09-23 20:05 2026-09-21 MEDP Medpace Holdings, Inc. Troendle August J. Director, Officer, 10% owner SELL $626.62 70,901 $44,428,148 433,372
2026-09-21 20:23 2026-09-17 MEDP Medpace Holdings, Inc. Troendle August J. Director, Officer, 10% owner SELL $620.40 10,880 $6,749,952 504,273
2026-09-18 10:07 2026-09-17 ICLR ICON PLC Murphy Ronan Martin Director OPT+S $175.00 5,005 $875,875 3,847
2026-09-18 10:08 2026-09-17 ICLR ICON PLC McCague Eugene Pacelli Director OPT+S $175.00 3,255 $569,625 3,811
2026-09-18 10:08 2026-09-16 ICLR ICON PLC CLIMAX JOHN DR Director OPT+S $175.00 5,005 $875,875 2,087
2026-09-17 20:04 2026-09-15 INCY INCYTE CORP CAGNONI PABLO J Officer OPT+S $120.49 23,218 $2,797,630 183,200
2026-09-17 20:39 2026-09-15 MEDP Medpace Holdings, Inc. Troendle August J. Director, Officer, 10% owner SELL $621.00 24,741 $15,364,149 515,153
2026-09-15 00:47 2026-09-10 ONMD OneMedNet Corp Yu Jeffrey Director, Officer, 10% owner BUY $0.63 142,857 $90,000 8,923,267
2026-09-04 21:00 2026-09-02 IQV IQVIA HOLDINGS INC. Berkshire James G. Officer OPT+S $261.33 2,668 $697,228 10,890
2026-08-31 20:11 2026-08-27 MEDP Medpace Holdings, Inc. Troendle August J. Director, Officer, 10% owner SELL $620.27 650 $403,176 539,894
2026-08-28 20:32 2026-08-26 MEDP Medpace Holdings, Inc. Kraft Robert O. Director OPT+S $617.81 3,858 $2,383,511 955
2026-08-27 20:21 2026-08-25 CRL CHARLES RIVER LABORATORIES INTERNATIONAL, INC. FOSTER JAMES C Director OPT+S $300.00 33,561 $10,068,300 31,596
2026-08-27 20:12 2026-08-25 MEDP Medpace Holdings, Inc. Troendle August J. Director, Officer, 10% owner SELL $620.08 4,673 $2,897,636 540,544
2026-08-25 20:24 2026-08-21 MEDP Medpace Holdings, Inc. Troendle August J. Director, Officer, 10% owner SELL $623.93 15,978 $9,969,094 545,217
2026-08-24 20:27 2026-08-20 MEDP Medpace Holdings, Inc. Brady Kevin M. Officer OPT+S $625.24 3,400 $2,125,816 12,830
2026-08-21 20:13 2026-08-19 MEDP Medpace Holdings, Inc. Troendle August J. Director, Officer, 10% owner SELL $614.30 42,783 $26,281,392 561,195
2026-08-21 20:11 2026-08-19 MEDP Medpace Holdings, Inc. DAVENPORT FRED B JR Director OPT+S $606.15 7,283 $4,414,590 3,798
2026-08-21 20:12 2026-08-19 MEDP Medpace Holdings, Inc. Carley Brian T Director SELL $608.63 5,000 $3,043,150 27,825
2026-08-21 18:44 2026-08-06 BUDZ WEED, INC. BREEN NICOLE M Director, Officer, 10% owner SELL $0.11 230,000 $24,495 29,869,930
2026-08-20 21:15 2026-08-19 INCY INCYTE CORP CAGNONI PABLO J Officer SELL $125.56 10,801 $1,356,174 183,200
SHOW ENTRIES

Sector-Wide Insider Alpha

Analyzing insider movements across the Services-Commercial Physical & Biological Research sector provides a macro-view of executive conviction. When multiple leaders in different companies within the same SIC code (8731) simultaneously buy shares, it often indicates an industry-wide undervaluation or a positive shift in market cycles.

SEC Filings in Services-Commercial Physical & Biological Research

Every transaction in the Services-Commercial Physical & Biological Research industry is reported via Form 4 disclosures. By filtering these filings by industry, investors can detect institutional-scale sentiment shifts before they are reflected in broader market indices, following the capital flow of those with intimate industry knowledge.

UNDERSTANDING THE DATA

FILING DATE: The date and time when the transaction was reported to the SEC. This is when the public first receives the information.

TRADE DATE: The actual day the insider executed the purchase or sale in the market.

INDUSTRY: The specific market sector the company operates in. Useful for identifying broader institutional capital flows across sectors.

OWNED AFTER: The total number of shares held by the insider following the transaction. This highlights the insider's remaining conviction in the company.

CHANGE %: The percentage increase or decrease of the insider's total position. Large percentage changes often carry more weight than the dollar amount alone.

TRADE TYPES DEFINITIONS

BUY: An open market purchase. Typically indicates an insider's belief that the stock is undervalued or poised for growth.

SELL: An open market sale. While often used for diversification or liquidity, large or unexpected sales can be a warning signal.

OPT+S (OPTION EXERCISE & SALE): This occurs when an insider exercises their stock options and sells them immediately. Often part of a structured compensation plan.